Latest Breaking News On - Amsterdam rheumatology - Page 1 : comparemela.com

Patients with inflammatory rheumatic disease may be at higher risk for long COVID

Patients with inflammatory rheumatic disease may be at higher risk for long COVID
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Noord hollandLaura boekelAmsterdam university medical centerImmunology centerAmsterdam rheumatology

Long COVID Risk Not Higher With Rheumatic Diseases

Data from a prospective cohort study emphasize the limitations of applying current WHO criteria of long COVID in patients with inflammatory rheumatic diseases.

United statesNoord hollandKim lauperLaura boekelLeonardh calabreseWorld health organizationEuropean alliance of associationsAmsterdam university medical centerUniversity of genevaImmunology centerEuropean allianceAmsterdam rheumatologyMedscape medical newsLancet rheumatologyCleveland clinic019 novel coronavirus

Female patients with psoriatic arthritis less likely to achieve therapy goals on bDMARDs

Female patients with psoriatic arthritis who receive biologic disease-modifying antirheumatic drugs are more likely to have more severe disease and less likely to reach low or minimal disease activity vs. male patients, according to data.

Noord hollandVan kuijkHealth assessment questionnaireImmunology centerAmsterdam rheumatologyHealth assessment questionnaire disability indexPsoriatic arthritis impact

EULAR RA Recommendations: Start Methotrexate, Steroids First

Contrary to ACR guidance, EULAR recommends starting methotrexate and glucocorticoids but dose reduction and discontinuation are emphasized.

Noord hollandJosefs smolenRobert landeweEuropean alliance of associationsEuropean congressClinical immunology centerAmerican college of rheumatologyGlobal taskUniversity of viennaMedscape professional networkEuropean allianceAmerican collegeMedical universityAmsterdam rheumatologyGlobal task forcePlus glucocorticoids

EULAR: Routine, proactive therapeutic drug monitoring unnecessary in RMDs

Routine, proactive therapeutic drug monitoring for patients receiving biopharmaceuticals for rheumatic and musculoskeletal diseases is not recommended, according to new points-to-consider published by EULAR.

Noord hollandCharlottelm krieckaertAmerican college of rheumatologyImmunology centerAmsterdam rheumatology